drugset / Trial / NCT02762474
Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This trial is going to evaluate the efficacy and safety of IMRT / nab-TP chemotherapy for unresectable esophageal cancer, and to investigate the optimal concurrent chemotherapy regimen for local advanced and unresectable esophageal cancer patients.
Timeline
- Start
- 2014-07
- Primary completion
- 2017-11
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Nab-paclitaxel | Small molecule | — | — |